Profile
CNTG DHR-PB TMO DHR IDXX A
Company Name Centogene N.V. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $9.43M $916.76B $160.15B $141.09B $35.45B $30.30B
Employees 0.38K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Ms. Kim Stratton Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
CNTG DHR-PB TMO DHR IDXX A
Quant Rating Score 1 5 3 3 3 3
Quant Rating Strong Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
CNTG DHR-PB TMO DHR IDXX A
Last Close $0.325 $1261.26 $424.24 $197.14 $437.44 $106.28
High 52 $0.54 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $0.29 $1261.26 $419.59 $174.64 $361.04 $99.29
Price vs. 52 Week High -39.81 % 0 % -32.04 % -29.78 % -20.25 % -31.27 %
Price vs. 52 Week Low 12.07 % 0 % 1.11 % 12.88 % 21.16 % 7.04 %
Total Return
CNTG DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % -17.41 % -6.31 % 4.72 % -11.36 %
3 Month Return 0 % 0 % -26.2 % -19.8 % 0.48 % -29.82 %
6 Month Return 0 % 0 % -23.47 % -19.66 % -3.09 % -18.37 %
9 Month Return -4.41 % 0 % -30.12 % -28.03 % -6.87 % -22.6 %
YTD Return 0 % 0 % -18.45 % -14.12 % 5.8 % -20.89 %
1 Year Return -33.52 % 0 % -26.04 % -20.05 % -12.39 % -22.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CNTG DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.57 % - 0.91 %
Dividend Paid and Capex Coverage Ration (TTM) -13.93 % 2.93 % 4.05 % 2.93 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Growth
CNTG DHR-PB TMO DHR IDXX A
Asset Growth -16.87 % -8.22 % -1.42 % -8.22 % 1.03 % 10.06 %
Gross Profit Growth -12.71 % 1.23 % 5.81 % 1.23 % 8.63 % 2.02 %
Revenue Growth 2.24 % -0.06 % 0.05 % -0.06 % 6.46 % -4.73 %
Revenue 3 Year -71.75 % -21.41 % 12.79 % -21.41 % 25.48 % 8 %
Revenue 5 Year -14.88 % 29.31 % 75.79 % 29.31 % 69.43 % 36.52 %
Revenue 10 Year 24.53 % 14.22 % 164.64 % 14.22 % 219.02 % 7.08 %
EBIT Growth 18.78 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Net Income Growth 8.19 % -18.16 % 5.67 % -18.16 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share -24.22 % -41.24 % -15.42 % -41.24 % 23.4 % 11.67 %
Net Income 5 Yeari Growth Per Share -122.47 % 25.73 % 79.48 % 25.73 % 117.19 % 30.32 %
Net Income 10 Yeari Growth Per Share -370.68 % 42.96 % 248.59 % 42.96 % 493.59 % 197.81 %
Operating Income Growth 18.78 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -19.86 % -6.64 % 3.1 % -6.64 % 2.48 % -1.19 %
Operating 3 Year CFG -380.41 % -22.42 % -6.33 % -22.42 % 27.28 % 23.6 %
Operating 5 Year CFG -392.43 % 64.18 % 82.49 % 64.18 % 111.7 % 85.69 %
Operating 10 Year CFG -1721.46 % 69.53 % 244.88 % 69.53 % 379.04 % 182 %
EPS Growth 11.81 % -17.86 % 6.76 % -17.86 % 6.1 % 5.21 %
EPS Diluted Growth 12.5 % -17.08 % 7.06 % -17.08 % 6.26 % 5.73 %
Book Value Per Share -426.92 % -7.44 % 7.15 % -7.44 % 8.46 % 2.3 %
Share Holder 3 Year Equity Growth Per Share -128.77 % 6.35 % 25.29 % 6.35 % 139.34 % 14.73 %
Share Holder 5 Year Equity Growth Per Share -165.79 % 58.77 % 74.85 % 58.77 % 840.53 % 34.5 %
Share Holder 10 Year Equity Growth Per Share -697.85 % 101.9 % 151.37 % 101.9 % 1550.96 % 27.76 %
Dividend Per Share Growth - -6.53 % 12.64 % -6.53 % - 4.82 %
Dividend 3 Year Growth Per Share - 0.35 % 52.23 % 0.35 % - 21.71 %
Dividend 5 Year Growth Per Share - 41.45 % 105.55 % 41.45 % - 44.02 %
Dividend 10 Year Growth Per Share - 221.34 % 158.83 % 221.34 % - 78.77 %
Debt Growth 33.74 % -18.07 % -10.43 % -18.07 % -7.53 % 23.95 %
Free Cash Flow Growth -19.05 % -8.39 % 4.91 % -8.39 % 3.26 % -6.85 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
CNTG DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 35.54 % 59.74 % 41.74 % 59.74 % 61.08 % 53.97 %
Return on Assets TTM -46.05 % 4.76 % 6.58 % 4.76 % 26.96 % 10.57 %
Return on Equity TTM 397.65 % 7.47 % 13.34 % 7.47 % 55.82 % 20.95 %
Return on Capital Employed TTM -87.78 % 6.66 % 8.53 % 6.66 % 50.78 % 14.73 %
Net Income Per EBT TTM 100.81 % 83.59 % 92.18 % 83.59 % 80 % 84.78 %
EBT Per Ebit TTM 118.83 % 93.35 % 96.45 % 93.35 % 98.21 % 100.34 %
EBIT Per Revenue TTM -61.11 % 20.26 % 17.08 % 20.26 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM -39.49 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Receivables Turnover TTM 2.5 6.79 5.07 6.79 6.94 4.92
Payables Turnover TTM 5.56 5.57 - 5.57 13.28 5.5
Inventory Turnover TTM 12.7 3.79 4.78 3.79 3.97 3.02
Fixed Asset Turnover TTM 251.78 % 466.14 % 459.74 % 466.14 % 470 % 359.75 %
Asset Turnover TTM 62.91 % 30.11 % 43.31 % 30.11 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM -1.13 8.72 21.53 8.72 11.29 5.95
Free Cash Flow Per Share TTM -1.21 6.84 17.79 6.84 9.7 4.94
Cash Per Share TTM 64.53 % 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM -65.41 % 26.23 % 18.97 % 26.23 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 107.18 % 78.46 % 82.61 % 78.46 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM -39.49 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Price To Free Cash Flows Ratio TTM -0.24 28.68 23.82 28.78 44.42 21.51
Price To Operating Cash Flows Ratio TTM -0.25 22.53 19.7 22.6 38.75 17.85
Price Cash Flow Ratio TTM -0.25 22.53 19.7 22.6 38.75 17.85
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
ADVB Advanced Biomed Inc. Common Stock 1.81
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.539
BIAF bioAffinity Technologies, Inc. 0.499
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
DHR Danaher Corporation 197.14
ETFs With Exposure to CNTG
Ticker ETF Name Weight Percentage Price
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.15 72.5283
Unlock